IP Library Patent Application 14863503
Patent Application
App. No. 14/863,503

METHOD AND KIT FOR GENETIC ANALYSIS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/863,503
Abstract

Methods and kits for assessing severity index for alcohol abuse, drug abuse, and other reward deficiency syndromes. It has been discovered that a multifaceted non-specific RDS behaviors should be considered as the true “reward” phenotype (endophenotype) instead of a single subset RDS behavior such as alcoholism. In an embodiment of the present invention, it has been discovered that there are at least eleven risk alleles associated with ten candidate genes. The methods and kits of the present invention satisfy the need to classify patients at genetic risk for drug/alcohol seeking behavior prior to or upon entry to residential and or non-residential chemical dependency and pain programs.

Claims (26)

1 - 11 . (canceled)

12 . A method comprising a genotypic analysis of a panel of genes to identify a plurality of alleles comprising:

(a) allele G of gene DRD1;

(b) allele A1 of gene DRD2;

(c) allele C of gene DRD3;

(d) allele C of gene DRD4;

(e) allele 9R of gene DAT1;

(f) allele 7-11R of gene DRD4;

(g) allele S or L of gene HTTLPR;

(h) allele 4R of gene MAOA;

(i) allele G of gene COMT;

(j) allele G of gene OPRM1; and

(k) allele 181 of gene GABRB3.

13 . A kit for analyzing a panel of genes comprising primers for sequencing (5′ to 3′) consisting of:

(l) allele G of gene DRD1;

(m) allele A1 of gene DRD2;

(n) allele C of gene DRD3;

(o) allele C of gene DRD4;

(p) allele 9R of gene DAT1;

(q) allele 7-11R of gene DRD4;

(r) allele S or L of gene HTTLPR;

(s) allele 4R of gene MAOA;

(t) allele G of gene COMT;

(u) allele G of gene OPRM1; and

(v) allele 181 of gene GABRB3.

14 - 19 . (canceled)

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2025
From: IVITALIZE IP HOLDINGS, INC
To: LIFE MAP, LLC
Reel/Frame 072972/0466 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2025
From: IVITALIZE IP HOLDINGS, INC
To: LIFE MAP, LLC
Reel/Frame 072975/0744 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2022
From: GENEUS HEALTH LLC
To: IVITALIZE IP HOLDINGS, INC.
Reel/Frame 059695/0609 →
RELEASE OF SECURITY INTEREST Recorded Jul 20, 2020
From: FUNDING SOURCE INTERNATIONAL, LLC
To: GENEUS HEALTH, LLC
Reel/Frame 053248/0742 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2020
From: GENEUS HEALTH IP, LLC
To: GENEUS HEALTH, LLC
Reel/Frame 052667/0038 →
SECURITY INTEREST Recorded Feb 7, 2020
From: GENEUS HEALTH, LLC
To: FUNDING SOURCE INTERNATIONAL, LLC
Reel/Frame 051749/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2019
From: GENEUS HEALTH LLC
To: GENEUS HEALTH IP, LLC
Reel/Frame 051154/0386 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2019
From: IGENE LLC
To: GENEUS HEALTH LLC
Reel/Frame 050383/0232 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2016
From: BLUM, KENNETH
To: SYNAPTAMINE, INC.
Reel/Frame 040231/0031 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2016
From: SYNAPTAMINE, INC.
To: IGENE LLC
Reel/Frame 040231/0171 →